Great Valley Advisor Group, Inc. Abb Vie Inc. Transaction History
Great Valley Advisor Group, Inc.
- $4.07 Billion
- Q4 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 84,130 shares of ABBV stock, worth $16.5 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
84,130
Previous 82,876
1.51%
Holding current value
$16.5 Million
Previous $16.4 Million
8.66%
% of portfolio
0.37%
Previous 0.43%
Shares
25 transactions
Others Institutions Holding ABBV
# of Institutions
4,198Shares Held
1.29BCall Options Held
17.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA173MShares$33.9 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.6 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.78 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $347B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...